A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes | MicrobiomeTrials

← Back to trials

NCT07282613

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2026-08-04Est. Completion: 2029-09-07

Enrollment target: 80 participants

Locations

Yale School of Medicine, New Haven, Connecticut, United States
Encore Medical Research Boynton Beach, Boynton Beach, Florida, United States
Nemours Chld Clnc Jacksonville, Jacksonville, Florida, United States
Innovus Clinical, Kissimmee, Florida, United States
D&H National Research Centers, Tamarac, Florida, United States
Clinical Research Trials of Florida, Tampa, Florida, United States
Columbus Research Foundation, Columbus, Georgia, United States
Eastside Bariatric and Gen Surg, Snellville, Georgia, United States
SIU Medicine, Springfield, Illinois, United States
Riley Hospital For Children, Indianapolis, Indiana, United States
University of Iowa, Iowa City, Iowa, United States
Great Lakes Research Inst., Southfield, Michigan, United States
UBMD Pediatrics, Buffalo, New York, United States
NYU Langone Orthopedic Center, New York, New York, United States
Children's Hosptl Philadelphia, Philadelphia, Pennsylvania, United States
Monument Health Clinical Rsrch, Rapid City, South Dakota, United States

Other microbiome trials you might be interested in

Effect of Digital-Supported Foot Care Education in Individuals With Type 2 DiabetesRecruiting

Type 2 Diabetes Mellitus (T2DM)

This randomized controlled trial will evaluate the effect of digital-supported foot care education on foot care knowledg…

Siirt, Turkey (Türkiye)Est. completion Jul 15, 2027

Extracellular Vesicle-based Strategy to Stratify Islets and Improve Their FItness Before TransplantationRecruiting

Type 1 Diabetes (T1D)

Islet transplantation restores glucose tolerance in people living with diabetes characterised by high glycaemic variabil…

Strasbourg, FranceEst. completion Jan 2032

A Natural History of Cardiometabolic Disease Among US Bhutanese: Developing the Cross-Sectional Bhutanese Community of Central Ohio Health Study to Understand Acculturation as Synergizing Socioenvironmental and Biobehavioral Risk Factors Propagating ...Recruiting

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.